Picture of Aspen Aerogels logo

ASPN — Aspen Aerogels News Story

0.000.00%
us flag iconLast trade - 00:00
Basic MaterialsSpeculativeSmall CapNeutral

Aspen Aerogels Inc expected to post a loss of 57 cents a share - Earnings Preview

* Aspen Aerogels Inc  ASPN.N   ASPN.K  is expected to show a
rise
in quarterly revenue when it reports  results on October 26. 
    * The Northborough Massachusetts-based  company is expected
to
report  a 64.6% increase in revenue to $50.013 million from
$30.38 million a year ago, according to the mean estimate from 9
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Aspen Aerogels Inc
is for
a loss of 57 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had risen by
about 0.4%
in the last three months. ​
    * Wall Street's median 12-month price target for Aspen
Aerogels
Inc is $33.5​, above​ its last closing price of $8.99. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.61       -0.57      -0.68     Missed  -18.4
 Mar. 31 2022  -0.49       -0.48      -0.59     Missed  -23.2
 Dec. 31 2021  -0.29       -0.29      -0.50     Missed  -72.4​
 Sep. 30 2021  -0.25       -0.25      -0.36     Missed  -42.2
 ​​Jun.        -0.28       -0.27      -0.23     Beat    15.9
 30 2021                                                
 Mar. 31 2021  -0.20       -0.20      -0.22     Missed  -8.6​
 Dec. 31 2020  -0.15       -0.15      -0.23     Missed  -57.5
 Sep. 30 2020  -0.16       -0.16      -0.25     Missed  -53.1
 This summary was machine generated October 25 at 00:37 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Aspen Aerogels

See all news